[所有老年患者都能从骨质疏松症药物治疗中受益吗?]
1Klinik für Orthopädie und Traumatologie des Bewegungsapparates, Universitätsspital Basel, Basel, Schweiz.
Praxis
|February 21, 2024
概括
新的骨质疏松症药物可以更快地减少骨折. 然而,临床的"惊喜问题"可能更好地指导老年患者的治疗,这些老年患者有高风险再次骨折.
科学领域:
- 骨质疏松症药物开发和治疗原则.
- 了解骨折风险的时间依赖性.
- 骨质疏松症管理的临床指南.
背景情况:
- 与抗吸收疗法相比,骨类合成药物可以更快地减少骨折.
- 在最初的脆弱性骨折后,重新骨折的风险取决于时间.
- 一个"迫在眉的骨折风险"类别确定了65岁以上最近骨折的患者.
研究的目的:
- 批判性地评估对老年患者更新的骨质疏松症治疗指南的严格应用.
- 为启动骨质疏松症治疗提出一种替代的临床方法.
- 为了确定那些可能对新开始的骨质疏松症治疗没有反应的患者.
主要方法:
- 对老年患者骨质疏松症治疗反应现有数据的分析.
- 建议修改"疑问惊喜"为骨科指示的临床评估工具.
- 基于临床判断对骨折复发风险的评估.
主要成果:
- 超过30%的患有骨折风险迫在眉的老年患者可能不会从新开始的骨质疏松症治疗中受益.
- "问题惊喜"方法建议治疗,如果骨折在一年内再次发生,就不会令人惊.
结论:
- 严格执行骨质疏松指南的算法可能会导致一些老年患者过度治疗.
- 为个性化骨质疏松症管理,建议使用诸如"问题惊喜"之类的工具进行临床基础的指示.
- 个性化评估对于优化治疗结果和避免老年骨质疏松症患者不必要的干预至关重要.
相关概念视频
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Alzheimer's Disease: Treatment
189
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
189
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Role of Vitamins in Maintaining Bone Health
3.3K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.3K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
158
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
158
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K


